Access clinical efficacy, prescribing guidelines, and documentation for Apogee.
Headache and respiratory patients often experience suboptimal outcomes with traditional treatment options. Apogee offers a differentiated approach that seeks to improve these outcomes.
A clinical overview of oxygen delivery mechanics and their impact on therapy effectiveness.
Studies indicate that approximately 80% of the population breathes through a dominant nasal passage that alternates throughout the day. This physiological phenomenon is known as the “nasal cycle.”
Traditional nasal cannulas deliver oxygen equally to both nostrils, which may waste oxygen on the blocked side. For clinicians, it is critical to consider these effects when prescribing oxygen therapy to ensure patients receive the intended prescribed dosage consistently.
Clinical research shows that effective oxygen therapy depends not only on flow rate, but on how oxygen is delivered to the patient.
In headache disorders, 100% oxygen has demonstrated strong efficacy as an acute intervention. However, studies indicate that increasing flow rates alone does not consistently improve outcomes and may increase the risk of oxygen-related side effects. Instead, therapeutic success is closely linked to delivering oxygen efficiently and consistently during the acute treatment window.
Download essential forms for insurance authorization and patient prescriptions.
A template to help justify clinical need and secure insurance coverage for patients.
Prescription form for Apogee therapy in primary headache disorders.
Prescription form for Apogee therapy in chronic respiratory conditions.
Read feedback from leading clinicians and researchers regarding Dynamic Oxygen Delivery™.
“This targeted oxygen delivery should not only enhance saturation, but will virtually cut oxygen use by half. A brilliant discovery!”
“Patients no longer need to suffer nasal irritation for the benefits of life-sustaining oxygen.”
